Literature DB >> 15322021

Comparison of disseminated and nondisseminated strains of Borrelia burgdorferi sensu stricto in mice naturally infected by tick bite.

Marc C Dolan1, Joseph Piesman, Bradley S Schneider, Martin Schriefer, Kevin Brandt, Nordin S Zeidner.   

Abstract

Clinical isolates of Borrelia burgdorferi sensu stricto have been categorized into disseminated and nondisseminated groups based on distinct ribosomal spacer restriction fragment length polymorphism genotypes (RSTs). In order to determine whether transmission by tick bite would alter the dissemination dynamics and disease produced by distinct genotypes, disseminated isolates (RST1), nondisseminated isolates (RST3), and a standard laboratory strain (B-31) were established in a murine cycle utilizing infections transmitted by ticks. B-31 spirochetes circulated in the blood of inbred C3H/HeJ mice longer than in the blood of outbred mice. The majority of C3H mice exposed to RST1-infected ticks contained cultivable spirochetes in their blood for up to 17 days; in contrast, mice exposed to RST3 isolates demonstrated a precipitous decline in infection after day 7 postexposure. A quantitative PCR (q-PCR) assay demonstrated that the densities of spirochetes in blood were similar for the RST1 and RST3 isolates, except during the 2nd week postexposure, when the RST1 isolates displayed a markedly higher density in blood. Spirochete load in the heart and bladder of infected mice was measured by q-PCR at 8 weeks postexposure; the numbers of spirochetes in these tissues were similar for mice infected with either disseminated or nondisseminated strains. Similarly, histopathology samples of heart, bladder, and joint tissue obtained at 8 weeks postexposure did not reveal greater pathology in mice infected with the disseminated isolates. We conclude that although the spirochetemia induced by tick-transmitted disseminated isolates was more intense and of longer duration than that induced by nondisseminated isolates, the resultant pathologies produced by these strains were ultimately similar.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322021      PMCID: PMC517418          DOI: 10.1128/IAI.72.9.5262-5266.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Vector competence of Ixodes scapularis, I. spinipalpis, and Dermacentor andersoni (Acari:Ixodidae) in transmitting Borrelia burgdorferi, the etiologic agent of Lyme disease.

Authors:  M C Dolan; G O Maupin; N A Panella; W T Golde; J Piesman
Journal:  J Med Entomol       Date:  1997-03       Impact factor: 2.278

2.  Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease.

Authors:  G P Wormser; D Liveris; J Nowakowski; R B Nadelman; L F Cavaliere; D McKenna; D Holmgren; I Schwartz
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

3.  Genetic heterogeneity of Borrelia burgdorferi in the United States.

Authors:  D A Mathiesen; J H Oliver; C P Kolbert; E D Tullson; B J Johnson; G L Campbell; P D Mitchell; K D Reed; S R Telford; J F Anderson; R S Lane; D H Persing
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

4.  Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans.

Authors:  G Seinost; D E Dykhuizen; R J Dattwyler; W T Golde; J J Dunn; I N Wang; G P Wormser; M E Schriefer; B J Luft
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

5.  T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.

Authors:  W Zhong; L Gern; M Kramer; R Wallich; M M Simon
Journal:  Eur J Immunol       Date:  1997-11       Impact factor: 5.532

6.  Borrelia burgdorferi sensu stricto, a bacterial species "made in the U.S.A."?

Authors:  N Marti Ras; D Postic; M Foretz; G Baranton
Journal:  Int J Syst Bacteriol       Date:  1997-10

7.  Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens.

Authors:  D Liveris; S Varde; R Iyer; S Koenig; S Bittker; D Cooper; D McKenna; J Nowakowski; R B Nadelman; G P Wormser; I Schwartz
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis.

Authors:  D Liveris; A Gazumyan; I Schwartz
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

Review 9.  Lyme disease.

Authors:  D T Dennis
Journal:  Dermatol Clin       Date:  1995-07       Impact factor: 3.478

10.  Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons.

Authors:  D Postic; M V Assous; P A Grimont; G Baranton
Journal:  Int J Syst Bacteriol       Date:  1994-10
View more
  12 in total

1.  Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis.

Authors:  Kathryn L Jones; Gail A McHugh; Lisa J Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2009-07

2.  The coenzyme A disulphide reductase of Borrelia burgdorferi is important for rapid growth throughout the enzootic cycle and essential for infection of the mammalian host.

Authors:  Christian H Eggers; Melissa J Caimano; Robert A Malizia; Toru Kariu; Brian Cusack; Daniel C Desrosiers; Karsten R O Hazlett; Al Claiborne; Utpal Pal; Justin D Radolf
Journal:  Mol Microbiol       Date:  2011-10-12       Impact factor: 3.501

3.  Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease.

Authors:  Kathryn L Jones; Lisa J Glickstein; Nitin Damle; Vijay K Sikand; Gail McHugh; Allen C Steere
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

4.  Isolation of Borrelia burgdorferi sensu lato from blood of adult patients with borrelial lymphocytoma, Lyme neuroborreliosis, Lyme arthritis and acrodermatitis chronica atrophicans.

Authors:  V Maraspin; K Ogrinc; E Ružić-Sabljić; S Lotrič-Furlan; F Strle
Journal:  Infection       Date:  2010-12-10       Impact factor: 3.553

5.  An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle.

Authors:  Jean I Tsao; J Timothy Wootton; Jonas Bunikis; Maria Gabriela Luna; Durland Fish; Alan G Barbour
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-17       Impact factor: 11.205

6.  Molecular dissection of a Borrelia burgdorferi in vivo essential purine transport system.

Authors:  Sunny Jain; Adrienne C Showman; Mollie W Jewett
Journal:  Infect Immun       Date:  2015-03-16       Impact factor: 3.441

Review 7.  Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles.

Authors:  Jean I Tsao
Journal:  Vet Res       Date:  2009-04-16       Impact factor: 3.683

8.  Relapsing fever spirochetes retain infectivity after prolonged in vitro cultivation.

Authors:  Job E Lopez; Merry E Schrumpf; Sandra J Raffel; Paul F Policastro; Stephen F Porcella; Tom G Schwan
Journal:  Vector Borne Zoonotic Dis       Date:  2008-12       Impact factor: 2.133

9.  Evolution and distribution of the ospC Gene, a transferable serotype determinant of Borrelia burgdorferi.

Authors:  Alan G Barbour; Bridgit Travinsky
Journal:  MBio       Date:  2010-09-28       Impact factor: 7.867

10.  Experimental infections of the reservoir species Peromyscus leucopus with diverse strains of Borrelia burgdorferi, a Lyme disease agent.

Authors:  Elisabeth Baum; Fong Hue; Alan G Barbour
Journal:  mBio       Date:  2012-12-04       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.